Call for AusBiotech 2015 session proposals
AusBiotech is inviting session proposals for life science conference AusBiotech 2015. This is your opportunity to have a say and lead discussions, bringing new and diverse topics to the forefront of the life sciences industry.
The organisation is looking for topical session submissions that explore current trends, critical and emerging topics, breakthroughs and war stories from a range of areas, including, but not limited to:
- Regenerative medicine
- Research translational strategies
- New markets
- Business development and capital access
- Emerging technologies
- Clinical trials
Ideas submitted should be thought-provoking and encourage discussion on topics that matter to biotech locally and abroad. Each session will last for 1.5 hours (including Q&A) and should include one chair and three or four speakers. Please note that AusBiotech 2015 is a cross-disciplinary industry conference covering developments in the life sciences industry rather than a scientific conference.
Proposals can be submitted immediately and up until 20 February 2015. A decision on acceptance of submitted sessions will be made late March and will be based on the interest and quality of the session, potential to attract participants, subject overlap and number of available sessions at the conference.
For further information and to submit, please fill out the submission form with your contact details, a 200-word description and suggested speakers. The organisation is also asking which international plenary speakers you would like to hear from and why.
For queries regarding the program, email Sharlene Gunatilake on events@ausbiotech.org or call (03) 9828 1400
High-potency cannabis use leaves a unique mark on DNA
Frequent users of high-potency cannabis have changes in genes related to mitochondrial and immune...
Scaffold-based method for culturing antitumour bacteria
Bacteria-based cancer therapy represents an exciting new treatment option — but in order to...
mpox vaccine appears safe and effective in adolescents
Interim analysis of an mpox vaccine trial has found the vaccine is safe in adolescents and...